Is it possible to cut costs, increase efficiency, and improve quality—all at the same time? The GSK (GlaxoSmithKline) UAE division and their main logistics company GAC (Gulf Agency Company) exceeded their expectations when they implemented temperature monitoring solutions from TSS in outbound shipments from Dubai. Additionally, they reassured the safety of what's most valuable—the patient.

TSS, a leading Swedish Software-as-a-Service (SaaS) company specializing in automated temperature monitoring solutions, is thrilled to announce that it has been awarded the prestigious EcoVadis Silver Medal for its advanced sustainability performance. With an overall score of 65, TSS has secured its position among the top 13% of sustainable world-leading companies, firmly establishing itself as a trailblazer in the industry.

In an era where people can make instant cash transfers electronically from their phone and order physical goods to be delivered in hours to their location, there is a portion of the Clinical Supply Chain that seems mired in a staff intensive, manual, reactive business process. That process is evaluating temperature excursions for Clinical Trial material.

Where do the majority of your temperature excursions occur? Why not eliminate them?

We are glad to announce that we’re exhibiting at the next Clinical Trial Supply Europe conference organized by Arena International.

We’re glad to announce that we will participate in the Temperature Control and Logistics conference and exhibition for pharma supply chain professionals in Düsseldorf, Germany, on June 7th-8th.

Customer onboarding is one of the most important steps in making sure your customers are happy and confident in using your product. At TSS, we help companies in life sciences monitor complex temperature budgets with our advanced automated cloud software and temperature loggers. Making the onboarding process smooth is key to long-term customer satisfaction.

TSS, a leading provider of temperature-monitoring solutions for the life-science industry, proudly announces that it has retained the EcoVadis Silver Medal for the second consecutive year. This recognition is a testament to TSS’s ongoing commitment to sustainability, even as EcoVadis raised the bar for its assessment criteria in 2024.

Pharmaceutical companies are under pressure to bring new drugs to market quickly. This urgency is driven by the needs of patients, requirements from authorities, and investors. Clinical trials are a crucial part of this process, but they can be delayed by manual processes.

In the complex world of pharmaceuticals, sustainability is becoming a key part of business strategy. The push for a greener future is driven not only by government rules but also by the expectations of communities and customers. However, making the supply chain sustainable while balancing costs and maintaining high quality can be challenging. This requires careful planning and a commitment to long-term goals.

In the life-science industry, finding the right balance between cost and quality in the supply chain is crucial. This balance ensures that pharma companies remain financially healthy while delivering safe and effective products to patients. However, achieving this balance can be challenging due to the complexities of quality management, procurement, and temperature control.

World Telecommunication & Information Society Day (WTISD), celebrated annually on May 17th, highlights the pivotal role of digital technologies in fostering societal progress. This day serves as a reminder of the transformative power of innovation and digitalisation in building a sustainable future. At TSS, we are dedicated to leveraging advanced technologies to enhance the pharmaceutical supply chain while promoting sustainability.

Pharmaceutical companies are under pressure to bring new drugs to market quickly. This urgency is driven by the needs of patients, requirements from authorities, and investors. Clinical trials are a crucial part of this process, but they can be delayed by manual processes.

In the pharmaceutical industry, maintaining precise temperature control is paramount to ensuring product quality and compliance with regulatory standards. The integrity of pharmaceutical products is heavily reliant on storage conditions, with deviations in temperature potentially compromising their efficacy and safety.

Are you in pursuit of optimizing the temperature management of your clinical trials supply chain? Get inspired by experts from the field, and learn from their experiences.

The TSS User Forum is a platform for thought leadership and innovation in supply chain and temperature control technologies. This forum gathered industry experts from some of the most respected life science companies worldwide, covering topical realities such as automation benefits, data management, supply chain sustainability, and Direct-To-Patient.

Where do the majority of your temperature excursions occur? Why not eliminate them?

In an era where people can make instant cash transfers electronically from their phone and order physical goods to be delivered in hours to their location, there is a portion of the Clinical Supply Chain that seems mired in a staff intensive, manual, reactive business process. That process is evaluating temperature excursions for Clinical Trial material.

According to Lie Berglind, Chief Quality Officer at TSS, quality management is the soul of every organization. It is about doing what we say we should do, but also about measuring and determining how it was done, as well as documenting it to discover opportunities for improvement.

Two-way integrations between IRT and the temperature system unlock cold chain consistency in clinical development – protecting patients, maximizing value and minimizing operational costs.

Pharmaceutical supply chains are often defined by a lack of connectivity between tiers, stakeholders and operational islands. It doesn’t have to be that way.

Digital transformation is having a huge impact on pharma supply chains, supporting patient safety and giving companies a competitive advantage. But key to this process are the integrations between different systems.

Without a doubt, uncertainty and unpredictability will continue to increase. Whether you‘re a pharmaceutical company dealing with temperature excursions, or a manufacturer relying on critical assembly-line components, you’re bound to be affected. The amount of disruption in today’s business climate demands the ability to respond quickly, which can only be done if the entire supply chain is visible.

Akanksha Sharma joined TSS in 2021 as a Quality Engineer in our Validation team, where she helped make sure our systems and processes are working exactly as they should. Always keen to continue expanding her skills and experience, in 2022 Akanksha took on a new challenge within our company.

The Future of Temperature Monitoring: How to lower the CO2 footprint with a Circular Supply Solution

Are you in pursuit of optimizing the temperature management of your clinical trials supply chain? Get inspired by experts from the field, and learn from their experiences.

Where do the majority of your temperature excursions occur? Why not eliminate them?

In light of the recent EMA and FDA guidelines, this session will discuss what role temperature monitoring may play in decentralized (DCT) and direct-to-patient (DTP) studies.

Where do the majority of your temperature excursions occur? Why not eliminate them?

We are excited to join the 20th Anniversary edition of Clinical Trial Supply East Coast on the 19th and 20th October 2022 in the Sheraton King of Prussia. The conference covers all things CTS from reducing timelines and streamlining processes to handling clinical supplies in a decentralized trial world. Along speakers from Pfizer, Merck, Janssen and many more we will present how digitalization of temperature processes can improve business outcomes in clinical trials.

New technologies for tracking and temperature logging hold great potential, but which to choose? Get a copy of our latest white paper.

Temperature management is critical when it comes to ensuring patient safety in clinical development, but we continue to use legacy point solutions that require heavy manual processes and duplication of data.